Lipid Metabolism Practice Questions

Q: Farber's disease is caused by a deficiency in which enzyme?

Ceramidase. **Explanation:** **Farber’s disease** (also known as Farber’s lipogranulomatosis) is a rare autosomal recessive lysosomal storage disorder. It is caused by a deficiency of the enzyme **acid ceramidase**. 1. **Why Ceramidase is correct:** Acid ceramidase is responsible for breaking down **ceramide** into sphingosine and a free fatty acid within the lysosomes. When this enzyme is deficient, ceramide accumulates in various tissues, particularly in the joints, skin, and central nervous system. This leads to the classic clinical triad: **painful swollen joints, subcutaneous nodules, and a hoarse cry** (due to laryngeal involvement). 2. **Why other options are incorrect:** * **Alpha-galactosidase:** Deficiency of Alpha-galactosidase A causes **Fabry disease**, characterized by angiokeratomas, peripheral neuropathy, and renal failure. * **Debranching enzyme:** Deficiency of this enzyme (Amylo-1,6-glucosidase) causes **Cori disease (GSD Type III)**, a glycogen storage disorder presenting with hepatomegaly and hypoglycemia. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic:** "Farber’s is **C**eramide **A**ccumulation" (Farber = **C**eramidase). * **Pathognomonic finding:** Biopsy of nodules shows "Farber bodies" (comma-shaped structures or curvilinear bodies) within macrophages. * **Key Triad:** Arthritis (joint deformity), Subcutaneous nodules, and Hoarseness of voice. * Farber’s disease is unique among sphingolipidoses for its prominent involvement of the joints and larynx.

Q: Which enzyme is responsible for the conversion of testosterone to dihydrotestosterone?

Conversion of testosterone to dihydrotestosterone. **Explanation:** The enzyme responsible for the conversion of **Testosterone** to **Dihydrotestosterone (DHT)** is **5-alpha reductase**. DHT is a more potent androgen than testosterone and is essential for the development of male external genitalia and prostate growth. * **Why Option B is correct:** 5-alpha reductase reduces the double bond between C4 and C5 of the testosterone molecule, producing DHT. This occurs primarily in peripheral tissues like the skin, prostate, and seminal vesicles. * **Why Option A is incorrect:** This describes the **Cholesterol Side-Chain Cleavage enzyme (Desmolase/CYP11A1)**. It is the rate-limiting step in steroidogenesis, stimulated by ACTH in the adrenals and LH in the gonads. * **Why Option C is incorrect:** This is the function of **Aromatase (CYP19A1)**. It converts androgens (testosterone and androstenedione) into estrogens (estradiol and estrone), primarily in the ovaries and adipose tissue. * **Why Option D is incorrect:** LH synthesis is regulated by **GnRH** from the hypothalamus and negative feedback from sex steroids; it is not an enzymatic conversion process of testosterone. **High-Yield Clinical Pearls for NEET-PG:** 1. **5-alpha reductase deficiency:** Results in male pseudohermaphroditism (ambiguous external genitalia at birth but virilization at puberty). 2. **Pharmacology Link:** **Finasteride** and **Dutasteride** are 5-alpha reductase inhibitors used to treat Benign Prostatic Hyperplasia (BPH) and male pattern baldness. 3. **Aromatase Inhibitors:** Drugs like **Anastrozole** and **Letrozole** are used in the treatment of ER-positive breast cancer in postmenopausal women.

Q: Which enzyme in the fatty acid synthase complex utilizes pantothenic acid as a coenzyme?

Acyl carrier protein. **Explanation:** The **Acyl Carrier Protein (ACP)** is a crucial component of the Fatty Acid Synthase (FAS) multienzyme complex. It functions as the "arm" that carries the growing fatty acid chain between the different catalytic sites of the complex. 1. **Why ACP is correct:** ACP contains a prosthetic group called **4'-phosphopantetheine**, which is derived from **Pantothenic acid (Vitamin B5)**. This group contains a reactive sulfhydryl (-SH) group that forms a high-energy thioester bond with the acyl groups, allowing them to be shuttled through the various stages of fatty acid synthesis. 2. **Why other options are incorrect:** * **Acetyl transacylase:** This enzyme transfers the initial acetyl group from CoA to the ACP. While it interacts with ACP, the enzyme itself does not utilize pantothenic acid as its own coenzyme. * **Thioesterase:** This is the final enzyme in the FAS complex that releases the finished palmitate chain by hydrolyzing the thioester bond. It does not require a B5 derivative. * **Enoyl reductase:** This enzyme performs the final reduction step in each cycle. It utilizes **NADPH** (derived from Vitamin B3/Niacin) as a coenzyme, not pantothenic acid. **High-Yield Clinical Pearls for NEET-PG:** * **Vitamin B5 (Pantothenic acid)** is a constituent of both **Coenzyme A (CoA)** and **ACP**. * The FAS complex is a **homodimer**; each monomer has 7 enzyme activities and one ACP. * **NADPH** is the essential reducing agent for fatty acid synthesis, primarily sourced from the **HMP Shunt**. * The "swinging arm" mechanism of 4'-phosphopantetheine is functionally analogous to the lipoamide arm in the Pyruvate Dehydrogenase complex.

Q: In which form are bile acids primarily present in the body?

In salt form. ### Explanation **Correct Answer: C. In salt form** Bile acids (primary and secondary) are synthesized from cholesterol in the liver. Before being secreted into the bile, they are conjugated with either **glycine** or **taurine**. This conjugation significantly lowers their pKa (from approximately 6.0 to 2.0–4.0). At the physiological pH of the duodenum and gallbladder (pH ~7.0–8.0), these conjugated bile acids exist almost entirely in their **ionized, negatively charged state**. To maintain electrical neutrality, they associate with cations like **Sodium (Na⁺)** or **Potassium (K⁺)**, forming **bile salts**. Bile salts are much more efficient detergents than bile acids because they are more amphipathic and water-soluble, which is essential for the emulsification of dietary fats. **Why other options are incorrect:** * **A & B (Weak acids / Ionized form):** While bile acids are technically weak acids, they do not remain as free acids in the body. Although they exist in an "ionized form," the term **"salt form"** is the more accurate physiological description of their existence in bile and the intestine when paired with cations. * **D (Esterified form):** Cholesterol is often stored or transported in an esterified form (cholesterol esters), but bile acids are **conjugated** (via amide bonds), not esterified. --- ### High-Yield Clinical Pearls for NEET-PG: * **Rate-limiting enzyme:** Cholesterol 7α-hydroxylase (inhibited by bile salts; stimulated by cholesterol). * **Primary Bile Acids:** Cholic acid and Chenodeoxycholic acid (synthesized in the liver). * **Secondary Bile Acids:** Deoxycholic acid and Lithocholic acid (formed by bacterial action in the colon). * **Enterohepatic Circulation:** 95% of bile salts are reabsorbed in the **terminal ileum**; a deficiency in this process (e.g., Crohn’s disease) leads to steatorrhea and malabsorption.

Q: Which of the following is the most likely metabolic effect of insulin on adipose tissue?

Decrease in lipolysis. Insulin is the body’s primary anabolic hormone, functioning to store energy and prevent the breakdown of stored fuels. Its effect on adipose tissue is centered on promoting lipid storage and inhibiting lipid mobilization [2]. **Why "Decrease in lipolysis" is correct:** Insulin is a potent inhibitor of **Hormone-Sensitive Lipase (HSL)**. HSL is the enzyme responsible for breaking down stored triglycerides into free fatty acids and glycerol. By inhibiting HSL, insulin effectively **decreases lipolysis** [1], [4]. Simultaneously, insulin promotes the storage of fat by stimulating **Lipoprotein Lipase (LPL)**, which clears chylomicrons and VLDL from the blood to provide fatty acids for esterification within the adipocyte. **Analysis of Incorrect Options:** * **A & B: Decrease in glucose transport/phosphorylation:** These are incorrect because insulin **increases** glucose uptake in adipose tissue by recruiting **GLUT-4** transporters to the cell membrane [2], [4]. Once inside, insulin increases glucose phosphorylation (via hexokinase) to trap glucose for glycerol-3-phosphate production, which is essential for triglyceride synthesis [1], [4]. * **D: Decrease in lipoprotein lipase:** As mentioned, insulin **increases** LPL activity in adipose tissue to facilitate the uptake of exogenous fatty acids for storage. (Note: Insulin *decreases* LPL in muscle, diverting lipids toward storage rather than oxidation). **NEET-PG Clinical Pearls:** * **GLUT-4** is the only insulin-dependent glucose transporter (found in adipose tissue and skeletal muscle) [2]. * **Hormone-Sensitive Lipase (HSL)** is activated by glucagon, epinephrine, and ACTH (via cAMP), and inhibited by insulin [3], [4]. * **Lipodystrophy:** Repeated insulin injections at the same site can cause localized hypertrophy or atrophy of adipose tissue due to insulin’s potent lipogenic effects.

Q: Increased level of lipoprotein(a) predisposes to which of the following conditions?

Atherosclerosis. **Explanation:** **Lipoprotein(a) [Lp(a)]** is a specialized lipoprotein consisting of an LDL-like particle and a specific protein called **apolipoprotein(a)**, which is covalently linked to apolipoprotein B-100. **Why Atherosclerosis is the Correct Answer:** Lp(a) is highly atherogenic and thrombogenic due to two primary mechanisms: 1. **Structural Similarity to Plasminogen:** Apo(a) has a high degree of structural homology with plasminogen. It competes with plasminogen for binding sites on fibrin, thereby **inhibiting fibrinolysis** and promoting clot formation (thrombogenesis). 2. **LDL-like properties:** Like LDL, Lp(a) undergoes oxidative modification and is taken up by macrophages to form **foam cells**, leading to the development of atherosclerotic plaques. Elevated levels are an independent risk factor for coronary artery disease and stroke. **Analysis of Incorrect Options:** * **Liver Cirrhosis:** Chronic liver disease typically leads to *decreased* synthesis of lipoproteins (hypolipoproteinemia), not an increase in Lp(a). * **Nephrotic Syndrome:** While nephrotic syndrome causes generalized hyperlipidemia (increased LDL and VLDL), Lp(a) is not the primary diagnostic or causative marker for this condition. * **Pancreatitis:** Acute pancreatitis is classically associated with severe **Hypertriglyceridemia** (Type I, IV, or V hyperlipoproteinemia), specifically elevated Chylomicrons, rather than Lp(a). **High-Yield Clinical Pearls for NEET-PG:** * **Niacin** is one of the few pharmacological agents that significantly lowers Lp(a) levels. * Lp(a) levels are largely **genetically determined** and are not significantly affected by diet or exercise. * **Kringles:** The repeating structural units in Apo(a) are called "Kringle domains" (specifically Kringle IV), which mediate its interference with plasminogen.

Question 1

Which of the following best describes the properties of acetyl-CoA carboxylase?

Accepted Answer

Required Cofactor - Biotin; Intracellular Location - Cytoplasmic; Allosteric Modifier - Citrate; Enzyme That Catalyzes a Covalent Modification - AMP-activated protein kinase

Answer

Required Cofactor - Biotin; Intracellular Location - Mitochondrial; Allosteric Modifier - Citrate; Enzyme That Catalyzes a Covalent Modification - PKA

Answer

Required Cofactor - Thiamin; Intracellular Location - Mitochondrial; Allosteric Modifier - Acetyl-CoA; Enzyme That Catalyzes a Covalent Modification - PKA

Answer

Required Cofactor - Thiamin; Intracellular Location - Cytoplasmic; Allosteric Modifier - Acetyl-CoA; Enzyme That Catalyzes a Covalent Modification - AMP-activated protein kinase

Question 2

Farber's disease is caused by a deficiency in which enzyme?

Accepted Answer

Ceramidase

Answer

Alpha-galactosidase

Answer

Debranching enzyme

Answer

None of the above

Question 3

Fraternal twin sisters present with episodes of fasting hypoglycemia, hypoketonemia, and muscle weakness occurring only during periods of caloric deprivation. One twin dies at 5 months of age. The surviving twin develops a cardiomyopathy diagnosed at 3 years of age. Carnitine esters are elevated in muscle tissue and serum. Which of the following is the most likely diagnosis?

Accepted Answer

Long-chain acyl CoA dehydrogenase (LCAD) deficiency

Answer

a-L-Iduronidase deficiency

Answer

Acid maltase deficiency (a 1,4-glucosidase deficiency)

Answer

Carnitine uptake deficiency

Question 4

Which enzyme is responsible for the conversion of testosterone to dihydrotestosterone?

Accepted Answer

Conversion of testosterone to dihydrotestosterone

Answer

Conversion of cholesterol to pregnenolone and enhancing steroidogenesis

Answer

Aromatization of testosterone to estradiol

Answer

Increasing the synthesis of LH

Question 5

Which enzyme in the fatty acid synthase complex utilizes pantothenic acid as a coenzyme?

Accepted Answer

Acyl carrier protein

Answer

Acetyl transacylase

Answer

Thioesterase

Answer

Enoyl reductase

Question 6

Where does ketogenesis take place?

Accepted Answer

Hepatic mitochondria

Answer

Hepatic cytoplasm

Answer

Hepatic microsome

Answer

Hepatic lysosome

Question 7

In which form are bile acids primarily present in the body?

Accepted Answer

In salt form

Answer

Weak acids

Answer

In ionized form

Answer

In esterified form

Question 8

Which of the following is the most likely metabolic effect of insulin on adipose tissue?

Accepted Answer

Decrease in lipolysis

Answer

Decrease in glucose transport

Answer

Decrease in glucose phosphorylation

Answer

Decrease in lipoprotein lipase

Question 9

A clinical study involves subjects from families experiencing complications of atherosclerotic cardiovascular disease and tendinous xanthomas before age 30. Some children in these families exhibit early atheroma formation and benefit from treatment with pharmacologic agents that inhibit HMG-CoA reductase. Affected individuals in these families are most likely to have a mutation in a gene encoding a cell surface receptor for which of the following?

Accepted Answer

LDL cholesterol

Answer

Cortisol

Answer

Insulin

Answer

Leptin

Question 10

Increased level of lipoprotein(a) predisposes to which of the following conditions?

Accepted Answer

Atherosclerosis

Answer

Liver cirrhosis

Answer

Nephrotic syndrome

Answer

Pancreatitis

Lipid Metabolism — MCQs

Lipid Metabolism — MCQs

On this page

Practice by Chapter

Want unlimited practice?